JD Health Signs 20+ Global Brands at CIIE, Launches Inbound Medical Service
Current overview (not historical)
JD Health announced at the ninth China International Import Expo (CIIE) that it had signed more than 20 global pharmaceutical and health brands and officially launched a one-stop 'Come to China for Treatment' service offering full-process support to overseas patients. The brand agreements cover Pfizer, Merck, Novo Nordisk, Centrum and Caltrate across pharmaceuticals, nutrition and medical devices. The service supports appointments, visas, interpretation, treatment coordination and post-return follow-up, initially focusing on patients from Qatar, the United Arab Emirates, Kazakhstan and Indonesia.
Written with AI from the reporting · updated 11/6/2026
Expand the detailed fact route and sources
Story route
A station-by-station route from the first public evidence onward; every station carries its own evidence and uncertainty.
- 1Unclassified fact stationNov 5, 00:00recorded Nov 6, 16:34single sourcerevised
京东健康在进博会签约超20家全球品牌并推出来华就医服务
Read original source ↗ China News Service · FinanceReplay this moment in the explorerEvidence & revisions · 1 source records
- Subject：
- 京东健康
- Action：
- 在第九届进博会期间集中签约超过20家全球医药健康品牌，并正式推出“来华就医”一站式跨境医疗服务
- Object：
- 辉瑞、默克、诺和等跨国药企及海外患者
- Occurred (fact side)：
- Nov 5, 00:00
- Published (valid side)：
- Nov 6, 16:17
- First seen (known side)：
- Nov 6, 16:34
Fact stationSingle source · one-sided claimRevisedCopy may have been revised later; time replay is bounded. Layer labels group reading only, not causation between layers.
Uncertainty marks flag where to check the sources; they are not proven causation.
Report timeline
Explore every side through dated source reports.
- China News Service · FinanceRelated fact: single sourceSource report revisedJD Health to Sign Over 20 Global Pharma Brands at CIIE, Launches Medical Tourism Service
Report first recorded Nov 6, 16:34
During the 9th China International Import Expo (CIIE), JD Health announced plans to sign agreements with over 20 global pharmaceutical and health brands, including Pfizer, Merck, and Novo Nordisk, spanning pharma, nutrition, and medical devices. The company also officially launched a one-stop 'medical treatment in China' service for international patients, providing end-to-end assistance from visa support to medical follow-up. Additionally, by the third quarter of 2026, JD Health had launched over 100 new drugs online, surpassing the total for the entire previous year.
Read original source ↗
Event activity trend
Not enough continuous observations to chart activity.
Event discussion
Reader opinions are hosted on GitHub Discussions; posting requires a GitHub account. Comments are not verified facts.